Selvita S.A. Logo

Selvita S.A.

Preclinical CRO offering integrated drug discovery and development services for life sciences.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Selvita S.A. is one of Europe's largest preclinical Contract Research Organizations (CROs), providing integrated services for the pharmaceutical, biopharmaceutical, and chemical industries. The company specializes in drug discovery and development, with a mission to bridge the gap between early discovery and the clinical stages. Selvita offers a comprehensive scope of solutions, including high-quality research and development support and advanced analytical services. It supports client projects across various therapeutic areas, helping to accelerate the development of new therapies for patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 10:16
Director's Dealing
Powiadomienie 2
Polish 4.3 KB
2025-10-03 10:16
Director's Dealing
Powiadomienie 1
Polish 4.3 KB
2025-10-03 10:16
Major Shareholding Notification
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 808 bytes
2025-09-29 00:04
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
English 2.6 KB
2025-09-29 00:04
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
Polish 2.1 KB
2025-09-23 00:03
Regulatory News Service
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
English 2.5 KB
2025-09-23 00:03
Regulatory News Service
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
Polish 2.0 KB
2025-09-19 20:08
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
English 6.2 KB
2025-09-19 20:08
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
Polish 6.1 KB
2025-09-18 00:03
Audit Report / Information
Independent registered auditor's report on the review of the interim condensed …
English 105.2 KB
2025-09-18 00:03
Audit Report / Information
Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego skon…
Polish 330.4 KB
2025-09-18 00:03
Audit Report / Information
Independent registered auditor's report on the review of the condensed standalo…
English 127.7 KB
2025-09-18 00:03
Audit Report / Information
Raport niezależnego biegłego rewidenta z przeglądu skróconego jednostkowego spr…
Polish 330.0 KB
2025-09-18 00:03
Interim Report
Śródroczne jednostkowe sprawozdanie finansowe H1
Polish 1.0 MB
2025-09-18 00:03
Interim Report
Interim Consolidated Financial Statements H1
English 1.1 MB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.